Migraine and epilepsy in the pediatric population

Related Experiment Video

Updated: May 3, 2026

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
09:57

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization

Published on: September 20, 2024

3.5K

Christopher B Oakley1, Eric H Kossoff

  • 1Departments of Neurology and Pediatrics, Johns Hopkins University School of Medicine, 200 North Wolfe Street, Suite 2158, Baltimore, MD, 21287, USA, coakley1@jhmi.edu.

Current Pain and Headache Reports
|February 7, 2014
PubMed

Insights

Childhood epilepsy and migraine share symptoms, complicating diagnosis. Differentiating these neurological conditions in children requires careful history and testing, followed by targeted treatments.

Area of Science:

  • Pediatric Neurology
  • Neuroscience
  • Clinical Neurology

Background:

  • Childhood epilepsy and migraine are prevalent neurological disorders in children.
  • Similarities between epilepsy and migraine, and shared predisposing conditions, can complicate diagnosis.
  • Differentiating these conditions is crucial for effective management.

Purpose of the Study:

  • To review the epidemiology of childhood epilepsy and headache.
  • To explore the association between epilepsy and migraine in pediatric populations.
  • To outline methods for differentiating epilepsy from migraine and discuss treatment strategies.

Main Methods:

  • Literature review focusing on epidemiology, clinical presentation, and diagnostic approaches.
  • Analysis of shared risk factors and overlapping symptomatology.
  • Discussion of current treatment modalities for pediatric epilepsy and migraine.

Main Results:

  • Epilepsy and migraine present diagnostic challenges due to overlapping features.
  • A thorough medical history and appropriate ancillary tests are key to accurate differentiation.
  • Treatment strategies differ for acute episodes but may overlap for preventative care.

Conclusions:

  • Accurate differentiation of childhood epilepsy and migraine is achievable through detailed clinical evaluation.
  • Effective management requires condition-specific acute treatments and potentially overlapping preventative strategies.
  • Understanding the relationship between these conditions improves patient outcomes.

More Related Videos

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy10:22

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy

Published on: December 6, 2016

22.8K
Inducing Post-Traumatic Epilepsy in a Mouse Model of Repetitive Diffuse Traumatic Brain Injury07:07

Inducing Post-Traumatic Epilepsy in a Mouse Model of Repetitive Diffuse Traumatic Brain Injury

Published on: February 10, 2020

10.0K

Related Concept Videos

Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
47
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.7K
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.5K
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
42
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.3K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410